H.R. 6166: To expand the drug price negotiation program under title XI of the Social Security Act and repeal certain changes to the program made by Public Law 119-21, to apply prescription drug inflation rebates under the Medicare program to drugs furnished in the commercial market, and to establish out-of-pocket limits on expenditures for prescription drugs under private health insurance.
Sponsors
3 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Nov. 20, 2025 | Introduced in House |
| Nov. 20, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.